Diagnos
Highly Engaged Employees
Highly Engaged EmployeesHealthcare Software · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7005 Taschereau Blvd Ste 265, Brossard, ...Phone Number
(450) 678-8882Website
www.diagnos.comRevenue
<$5 MillionStock Symbol
ADKIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Diagnos
Diagnos is a leader in artificial intelligence and healthcare technical services, specializing in algorithm development, data analysis, and image processing since 2001. The company aims to assist healthcare professionals in the early detection of critical health issues, particularly focusing on screening services to prevent vision loss and other complications from chronic diseases. Their CARA platform enhances the monitoring of eye diseases, enabling primary care facilities to better manage conditions such as diabetic retinopathy. Diagnos serves a global clientele, including government healthcare systems, and emphasizes cost-effective solutions for improving patient well-being.Explore more
Diagnos Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Diagnos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Diagnos has new funding data
Website visits: Recent activity has been detected on your website
Check out if Diagnos is spiking on competitors!
Product Launch: Get notified when Diagnos launches new products
Diagnos, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Diagnos has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Diagnos recently announced quarterly report
Click to see if Diagnos had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Diagnos
Recommended Actions
Reach out to Masked Content who joined Diagnos as Masked Content
Find 2 more new buyers
Compare Similar Companies to Diagnos
Compare insights from companies similar to Diagnos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Diagnos is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Diagnos is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Diagnos.
Diagnos financials insights
Gather financial insights about Diagnos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Share Placement
$396K
Diagnos Tech Stack
A closer look at the technologies used by Diagnos
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Business Development
Executive Move
Board of Directors
Funding
Funding
Promotion
Executive Move
Diagnos has announced that Yves-Stéphane Couture has been promoted from Vice President, Sales to the role of Chief Operating Officer.
Funding
Funding
Diagnos News & Media
DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026
DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.DIAGNOS Announces Amendment to Convertible Debentures
BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (AI) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 1DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA
BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to provide an update to the press release dated January 13, 2026 on the regulatory pathway for the future version of its flagship product CARA, which incorporates eye-related disease detection algorithms, and April 1, 2026 announcemeDIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
BROSSARD, Quebec, April 01, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that the annual registration for its medical device establishment with the U.S. Food and Drug Administration (FDA) has been successfully completed.
Read more news
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Diagnos
Sign Up For FreeTo access detailed company insights
Diagnos is a leader in artificial intelligence and healthcare technical services, specializing in algorithm development, data analysis, and image processing since 2001. The company aims to assist healthcare professionals in the early detection of critical health issues, particularly focusing on screening services to prevent vision loss and other co... Read More
